President & CEO at Adaptive Biotechnologies Corporation
Location:
Seattle, Washington
Industry:
Biotechnology
Work:
Adaptive Biotechnologies Corporation since Sep 2009
President & CEO
Connaught Real Estate Finance Sep 2007 - Jan 2009
President & COO
Pulte Homes Jul 2003 - Sep 2006
VP Operations
Healthaxis 1999 - 2000
Director of Business Development
Wasserstein Perella 1997 - 1999
Associate
Education:
University of Pennsylvania - The Wharton School 2000 - 2002
Master of Business Administration (MBA), Finance and Marketing
Cornell University 1992 - 1996
Bachelor of Science (BS), Entrepreneurship/Entrepreneurial Studies
Speaking at an investor conference last week, prior to the authorization, the companys CEO, Chad Robins, called the test the first stepping stone in what Ill call a franchise of T-Detect products.
Date: Mar 08, 2021
Category: More news
Source: Google
How to make millions from the race for a coronavirus vaccine
But just four of the CEOs of those firms, including Bancel, have sold company stock. Only one - Chad Robins of Adaptive Biotech - made substantial, regular sales under a 10b5-1 plan, like Moderna's Bancel. Adaptive Biotech, however, has seen a far smaller recent stock-price increase - about 50 perc